Packaging Corporation of America vs Zimmer Biomet Holdings Inc — how do they compare? Packaging Corporation of America trades at $229.6 (market cap $20.49B), while Zimmer Biomet Holdings Inc trades at $88.96 (market cap $16.95B). The key difference: Packaging Corporation of America is the larger of the two by market cap, and Packaging Corporation of America pays the higher dividend (2.61%). Which is the better fit depends on your goals — on Pluang, investors hold Packaging Corporation of America for 45 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| PKG | ZBH | |
|---|---|---|
Market Cap | $20.49B | $16.95B |
Volume | 493,499 | 2,505,240 |
Sector | Consumer Cyclical | Health |
52-Week High | $257.43 | $103.98 |
52-Week Low | $191.68 | $79.58 |
Typical Hold Time | 45 Days | 89 Days |
Enterprise Value | $24.30B | $24.02B |
Dividend Yield | 2.61% | 1.08% |
Signals from Pluang's Aura AI — not financial advice
Packaging Corporation of America (PKG) trades at $229.06, up 0.8% on the day, amid a bearish technical signal and mixed earnings performance. The stock shows strong profitability with a 7.26% net income margin and 14.79% ROE, though 2026 profit margins are projected to decline. Recent news highlights institutional buying and a steady dividend, while analyst consensus is a $272.43 price target with a 'Hold' bias.
PKG offers value through its dividend and stable business model but faces headwinds from cost pressures and negative cash flow trends. The stock's near-term performance hinges on Q3 2026 earnings results, with risks including margin compression and economic sensitivity. Upside exists if the company beats expectations and manages costs effectively.
Zimmer Biomet (ZBH) trades at $88.49, down 1.33% today, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.07 surpassing the $2.01 estimate. Revenue growth is steady, reaching $8.23B in 2025, though net income margin has moderated to 9.48%. A quarterly dividend of $0.24 was declared, payable in October 2026. Analyst consensus price target is $103.11, implying potential upside from current levels.
The outlook is mixed: solid fundamentals and earnings momentum support long-term value, but technical weakness and elevated debt levels pose near-term risks. Investment appeal hinges on execution of commercial transformation and robotics adoption offsetting competitive pressures. Key risks include margin compression and macroeconomic sensitivity affecting procedure volumes.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →